Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Peters

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
The Quarterly Journal of Medicine|January 1, 1993
Mitochondrial myopathy associated with chronic zidovudine therapy in AIDSB S Peters, J Winer, D N Landon, et al.
Lancet (London, England)|December 16, 1998
Lipid lowering therapy in patients with HIV infectionA S Wierzbicki, T M Reynolds, M A Crook, et al.
BMJ (Clinical Research Ed.)|March 28, 1992
Changing disease patterns in AIDSD G Coleman, E J Beck, B S Peters, et al.
Lancet (London, England)|March 3, 1990
Ineffectiveness of AL721 in HIV diseaseB S Peters, J M Bennett, D J Jeffries, et al.
The Quarterly Journal of Medicine|November 1, 1990
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapyB S Peters, D Fish, R Golden, et al.
Advances in Dental Research|March 29, 2011
Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3AV Ramirez-Amador, W Nittayananta, M Magalhães, et al.
Journal of Public Health Medicine|October 21, 1999
Controlled management of public relations following a public health incidentG M Holdsworth, A Breathnach, D Asboe, et al.
Drug Safety|June 1, 1994
Adverse effects of drugs used in the management of opportunistic infections associated with HIV infectionB S Peters, E Carlin, R J Weston, et al.
The Journal of Infection|February 12, 1998
A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjectsB S Peters, R Cheingsong-Popov, D Callow, et al.
European Journal of Nuclear Medicine|July 7, 2001
In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infectionR Kulasegaram, B Giersing, C J Page, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
The Quarterly Journal of Medicine|January 1, 1993
Mitochondrial myopathy associated with chronic zidovudine therapy in AIDSB S Peters, J Winer, D N Landon, et al.
Lancet (London, England)|December 16, 1998
Lipid lowering therapy in patients with HIV infectionA S Wierzbicki, T M Reynolds, M A Crook, et al.
BMJ (Clinical Research Ed.)|March 28, 1992
Changing disease patterns in AIDSD G Coleman, E J Beck, B S Peters, et al.
Lancet (London, England)|March 3, 1990
Ineffectiveness of AL721 in HIV diseaseB S Peters, J M Bennett, D J Jeffries, et al.
The Quarterly Journal of Medicine|November 1, 1990
Visceral leishmaniasis in HIV infection and AIDS: clinical features and response to therapyB S Peters, D Fish, R Golden, et al.
Advances in Dental Research|March 29, 2011
Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3AV Ramirez-Amador, W Nittayananta, M Magalhães, et al.
Journal of Public Health Medicine|October 21, 1999
Controlled management of public relations following a public health incidentG M Holdsworth, A Breathnach, D Asboe, et al.
Drug Safety|June 1, 1994
Adverse effects of drugs used in the management of opportunistic infections associated with HIV infectionB S Peters, E Carlin, R J Weston, et al.
The Journal of Infection|February 12, 1998
A pilot phase II study of the safety and immunogenicity of HIV p17/p24:VLP (p24-VLP) in asymptomatic HIV seropositive subjectsB S Peters, R Cheingsong-Popov, D Callow, et al.
European Journal of Nuclear Medicine|July 7, 2001
In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infectionR Kulasegaram, B Giersing, C J Page, et al.
Pageof 4